Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men - Wikidata - awgldk - TriplyDB

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

http://www.wikidata.org/entity/Q34448831

about

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans Fatty acids, obesity, and insulin resistance: time for a reevaluation Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus Triglycerides produced in the livers of fasting rabbits are predominantly stored as opposed to secreted into the plasma Similar VLDL-TG storage in visceral and subcutaneous fat in obese and lean women.Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance Hepatic ABCA1 and VLDL triglyceride production.Effects of exercise on VLDL-triglyceride oxidation and turnover Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study.Systemic free fatty acid disposal into very low-density lipoprotein triglycerides.Immunologic, metabolic and genetic factors in hepatitis C virus infection.Lipids and HCV.The regulation of ApoB metabolism by insulin.Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men.Lean body mass, not FFA, predicts VLDL-TG secretion rate in healthy men.Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system.Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.

P2860

Q26774776-FB8BC0D7-8607-445D-A6A5-025162454F65 Q26859157-D25A35AF-C9A2-479E-B2D3-8498FCDE5EB3 Q33596529-7C1E700B-16CF-412F-9BA5-4CAFA8B71C12 Q35214066-E4588307-FC00-42C5-9729-9213D55D886E Q35404743-B580FF51-D415-438E-98DD-87F1D853DE10 Q35489364-AA40ECFA-1B3C-488C-A9AF-17BCE621BA22 Q35737630-CF7B1C80-A2EC-47DE-80F7-97ED87A61BD9 Q35756428-42977AE2-5369-4A98-800E-34D479054D6F Q35793610-3E7CB42E-9E91-4D95-8DFA-8CE01790B66A Q36312713-68E64A1A-366B-4E90-A577-5A8F79E44752 Q36560629-FE244990-4EC7-4B71-A02A-8AB66006F232 Q36713843-62441E63-DB12-42BC-9552-F3BE87B4F062 Q36796043-26AA0BD3-9096-4745-AF73-A1B540E85A1D Q37014978-57FBEF17-1FAE-47A3-A6D3-D47E680A69CF Q37682496-1546A99A-8AF6-46CC-A76D-49A55A71ED08 Q38056643-5EDAC0AA-005F-47CE-9134-8ACF9A0A9B19 Q38110665-B6DE2DD2-5B4E-4EDC-95DF-52B4F3A6F9CD Q38259292-01DF78C2-1552-43D4-B6B6-562BB67430F2 Q40860246-D8657848-B8AC-4DFB-8D7B-5A9C7AA97EAF Q41941977-DBD19B59-2CBC-4A04-A07A-6F0510418732 Q47972882-7446CFB9-E9AD-40C5-B430-DD40F9EE98EB Q53801131-9E56FBE0-43A4-46DD-A26A-3D17D6F5E813

P2860

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

http://www.wikidata.org/entity/Q34448831

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@ast

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@en

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@nl

type

label

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@ast

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@en

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@nl

prefLabel

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@ast

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@en

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@nl

P1433

Q34448831-E945A715-0582-4EFB-AF8A-0E3663836DCD

P1476

Q34448831-20AA0C6A-65E4-4095-A214-10E5EEB06B1E

P2093

Q34448831-F0BABAD4-F25D-4C96-994A-ACCA9A23A296

Q34448831-F39C8569-5292-4BF6-9EE9-1501DAE6CC52

Q34448831-FCF1F18D-3ED6-4360-B098-B1A20FABEF21

Q34448831-FFCD4729-762B-478D-85F4-3982E975D3BB

P2860

Q34448831-038ACE8A-286A-48EF-8017-70F466B5E444

Q34448831-202AB975-BE44-4FB9-BBB3-DEC702E808BA

Q34448831-2B0A221F-8B9F-41F6-BFC0-DCA9A3D533CB

Q34448831-4900F32F-671F-4C97-AC46-1962998E9F39

Q34448831-6B3E0C37-2D19-4102-AB5F-CB527AD5906E

Q34448831-6E48D1AA-8D0E-44B2-AC95-E01590719424

Q34448831-79FC8B48-EA52-4989-AFA7-5D72C722FA5B

Q34448831-88399F37-FC25-4FC4-9822-C31183C5EC2A

Q34448831-8E745857-00D1-4CE2-B37A-B0D22F56F885

Q34448831-A9F2AB07-E9AA-4C56-8BE1-3FB7019D017B

P304

Q34448831-B1B9A588-CBFD-4688-84C9-93B43601055A

P31

Q34448831-5A3AD610-0130-47D7-90F9-A609632B84EC

P356

Q34448831-809AE95F-F63F-41BB-BD7D-E19BCA8BA223

P407

Q34448831-18893421-1933-4E58-A54D-28E45A7F264B

P433

Q34448831-15F46430-09AC-40ED-911C-BBEF8AB65EB3

P478

Q34448831-7033F18D-A6A4-4C98-9B12-9F40F1070B8A

P50

Q34448831-56BA6FC0-D3B0-4D00-A0A0-7D4100FC80A9

Q34448831-65394058-FA00-4440-A563-619D41E1DDEF

Q34448831-7F7E424C-6A12-4D72-BE13-804E24E914D0

Q34448831-87533920-66A8-4D8E-ACAC-652A0167BAB1

P577

Q34448831-A0F209DB-0872-4F4F-8D03-28B8399038A5

P5875

Q34448831-68636E2F-00CA-4C2F-878B-A63EEC934AB0

P698

Q34448831-E36FF483-667C-4051-A7B8-FC6DC86417E7

P921

Q34448831-2460EC61-75D9-4F7C-B156-6D3506764C9A

Q34448831-6D3EF87A-8E3D-476A-841D-1C436467E482

P932

Q34448831-3B83842B-33AC-4D88-801C-A0B0CA233E34

P356

P1433

P1476

Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men

@en

P2093

Jens S Christiansen

http://www.w3.org/2001/XMLSchema#string

Lars P Sørensen

http://www.w3.org/2001/XMLSchema#string

Ole Schmitz

http://www.w3.org/2001/XMLSchema#string

Søren Nielsen

http://www.w3.org/2001/XMLSchema#string

P2860

Fuel selection in human skeletal muscle in insulin resistance: a reexamination.

Lipid metabolism during endurance exercise.

Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are.

Diabetic dyslipidaemia: from basic research to clinical practice.

Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein.

New insight into the pathophysiology of lipid abnormalities in type 2 diabetes.

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans.

Low-density lipoprotein subclass patterns and risk of myocardial infarction.

P304

88-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB10-0564

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Esben Søndergaard

Lars Christian Gormsen

Iben R Andersen

P577

2010-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46393095

http://www.w3.org/2001/XMLSchema#string

P698

20858686

http://www.w3.org/2001/XMLSchema#string

P921

P932

3012201

http://www.w3.org/2001/XMLSchema#string